(LRGC) AB Active s - Overview
Etf: Large-Cap, Equity, ETF, Active
Dividends
| Dividend Yield | 0.59% |
| Yield on Cost 5y | 0.92% |
| Yield CAGR 5y | 119.04% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.6% |
| Relative Tail Risk | 4.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | -3.55 |
| Character TTM | |
|---|---|
| Beta | 0.941 |
| Beta Downside | 0.939 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.38% |
| CAGR/Max DD | 1.12 |
Description: LRGC AB Active s December 27, 2025
The LRGC ETF is an actively managed fund that targets large-cap U.S. equities, allocating at least 80 % of its net assets to this segment. Because it is classified as “non-diversified,” the portfolio can hold a concentrated set of holdings, which may amplify both upside potential and risk.
Key metrics (as of Q3 2025) show an expense ratio of 0.45 %, total assets under management of roughly $210 million, and an annual turnover rate near 45 %. Year-to-date performance has tracked the S&P 500 within a 0.8 % tracking error, reflecting the manager’s blend of active stock selection and large-cap exposure.
Primary drivers of LRGC’s performance include U.S. macro-economic conditions-particularly interest-rate trends and consumer confidence-that affect large-cap earnings, as well as sector weightings that skew toward technology and health-care, which together account for about 55 % of the portfolio. A slowdown in rate hikes could benefit these sectors, while a sharp recession would likely pressure the fund’s concentrated holdings.
For a deeper, data-driven assessment of LRGC’s risk-adjusted returns and sector tilts, you may find ValueRay’s analytical platform useful.
What is the price of LRGC shares?
Over the past week, the price has changed by -0.72%, over one month by -1.46%, over three months by +1.16% and over the past year by +11.76%.
Is LRGC a buy, sell or hold?
What are the forecasts/targets for the LRGC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87 | 11.2% |
LRGC Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 740.3m USD (740.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 740.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 740.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.38% (E(740.3m)/V(740.3m) * Re(9.38%) + (debt-free company))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)